Idexx Laboratories Inc

IDXX XNAS IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Market Cap

43B

Short interest (May 15)

2.6%

Net Short (Jun 03 ): -0.1%

Borrow Fee

0.40%

↑ 48.1%

Available Shares

900K

↓ 29.2%

Price Chart

Company Overview

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Company Info

Exchange: NASDAQ
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CIK: 0000874716
Asset Type: CS

Market Data

Market Cap: $43,450,332,407
Employees: 11,000
Status: Active

Short Interest

Current Borrow Fee 0.40%
Range: 0.40% - 0.40%
Available Shares 900K
Range: 850K - 900K

Recent Changes

Fee Change: ↓ 2.3%
Available Change: ↓ 2.9%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime